Latest filing published 04 Sept 2013 for VAXGEN INC, €8,372.
No signal scores available.
Robert Michael Richey is a declared insider of Vaxgen Inc, with filings sourced from SEC (Form 4). In total, 2 filings cover trades dated from 12 December 2012 to 3 September 2013.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 4 September 2013, reports an option exercise of €8,372 in Vaxgen Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations